Drug That Could Give Pancreatic Cancer Patients More Time is Out of Reach: Healthing.com PCC CEO Michelle Capobianco, pancreatic cancer researchers and patient advocates question the pan-Canadian Pharmaceutical Alliance (pCPA) delaying the funding of pancreatic cancer...
Access to Pancreatic Cancer Treatments: Pancreatic Cancer Canada CEO Michelle Capobianco Speaks to Newstalk 1010 Michelle Capobianco, Chief Executive Officer of Pancreatic Cancer Canada, speaks with John Moore of Newstalk 1010 about the bureaucracy that prevents new...
Promising Treatment for Deadly Cancer Blocked by Canadian Regulators See original press release on Newswire TORONTO, Aug. 19, 2020 /CNW Telbec/ – While innovations in health care are spurring extraordinary advances in the treatment of malignant tumours,...
Community fundraiser adapts amidst global pandemic Dedicated. Resilient. Compassionate. These are just a few words that describe Pam Kosolofski, a steadfast champion of progress for pancreatic cancer patients – even amidst a global pandemic. Each spring, Pam organizes...
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
Recent Comments